Mesoblast Limited (MESO) DCF Valuation

Mesoblast Limited (MESO) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

Mesoblast Limited (MESO) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Engineered for accuracy, our (MESO) DCF Calculator empowers you to evaluate Mesoblast Limited's valuation using real-world financial data, offering complete flexibility to modify all key parameters for enhanced projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 AY5
2024		 FY1
2025		 FY2
2026		 FY3
2027		 FY4
2028		 FY5
2029
Revenue 32.2 7.5 10.2 7.5 5.9 4.6 3.6 2.8 2.2 1.7
Revenue Growth, % 0 -76.81 36.95 -26.54 -21.32 -21.93 -21.93 -21.93 -21.93 -21.93
EBITDA -75.4 -107.6 -76.6 -58.6 -62.8 -4.6 -3.6 -2.8 -2.2 -1.7
EBITDA, % -234.5 -1443.17 -749.91 -780.56 -1064.44 -100 -100 -100 -100 -100
Depreciation 3.7 4.3 4.4 4.1 4.7 2.3 1.8 1.4 1.1 .8
Depreciation, % 11.4 57.19 42.89 54.75 79.06 49.06 49.06 49.06 49.06 49.06
EBIT -79.1 -111.9 -81.0 -62.7 -67.5 -4.6 -3.6 -2.8 -2.2 -1.7
EBIT, % -245.9 -1500.36 -792.8 -835.32 -1143.49 -100 -100 -100 -100 -100
Total Cash 129.3 136.9 60.0 70.9 62.6 4.6 3.6 2.8 2.2 1.7
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1.3 4.6 4.4 2.3 21.0
Account Receivables, % 4.11 61.56 43.12 30.34 355
Inventories -.3 -.3 .0 -4.3 .0 -.6 -.4 -.3 -.3 -.2
Inventories, % -0.78368 -3.38 0 -57.65 0 -12.36 -12.36 -12.36 -12.36 -12.36
Accounts Payable 25.0 19.6 23.1 20.1 7.1 4.4 3.4 2.7 2.1 1.6
Accounts Payable, % 77.66 262.85 226.02 268.56 119.79 95.53 95.53 95.53 95.53 95.53
Capital Expenditure -2.2 -1.6 -.2 -.3 -.3 -.4 -.3 -.2 -.2 -.1
Capital Expenditure, % -6.98 -22.09 -2.27 -4.19 -4.59 -8.02 -8.02 -8.02 -8.02 -8.02
Tax Rate, % 0.21668 0.21668 0.21668 0.21668 0.21668 0.21668 0.21668 0.21668 0.21668 0.21668
EBITAT -70.5 -110.9 -80.7 -62.5 -67.3 -4.5 -3.5 -2.7 -2.1 -1.7
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -45.2 -117.0 -73.2 -55.2 -99.0 14.0 -2.6 -2.1 -1.6 -1.3
WACC, % 15.49 15.51 15.51 15.51 15.51 15.5 15.5 15.5 15.5 15.5
PV UFCF
SUM PV UFCF 7.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -1
Terminal Value -9
Present Terminal Value -5
Enterprise Value 3
Net Debt 56
Equity Value -54
Diluted Shares Outstanding, MM 987
Equity Value Per Share -0.05

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real MESO financials.
  • Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
  • Forecast Flexibility: Modify forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe the effect of your inputs on Mesoblast’s valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • Customizable Forecast Inputs: Adjust essential factors such as revenue projections, EBITDA margins, and capital investments.
  • Instant DCF Valuation: Quickly computes intrinsic value, NPV, and other relevant metrics.
  • High-Precision Accuracy: Leverages Mesoblast Limited's (MESO) actual financial data for credible valuation results.
  • Simplified Scenario Analysis: Easily evaluate various assumptions and analyze different outcomes.
  • Efficiency Booster: Avoid the hassle of constructing intricate valuation models from the ground up.

How It Works

  • 1. Open the Template: Download and open the Excel file containing Mesoblast Limited’s (MESO) preloaded data.
  • 2. Edit Assumptions: Modify key inputs such as growth rates, WACC, and capital expenditures.
  • 3. View Results Instantly: The DCF model automatically calculates intrinsic value and NPV.
  • 4. Test Scenarios: Evaluate multiple forecasts to explore various valuation outcomes.
  • 5. Use with Confidence: Present professional valuation insights to enhance your decision-making.

Why Choose This Calculator for Mesoblast Limited (MESO)?

  • Accurate Data: Utilize real Mesoblast financials for dependable valuation outcomes.
  • Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to fit your forecasts.
  • Time-Saving: Pre-configured calculations save you from starting from the ground up.
  • Professional-Grade Tool: Tailored for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: Easy-to-navigate design and clear instructions ensure accessibility for all users.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Mesoblast Limited (MESO) stock.
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models for Mesoblast Limited (MESO).
  • Consultants: Deliver professional valuation insights on Mesoblast Limited (MESO) to clients quickly and accurately.
  • Business Owners: Understand how companies like Mesoblast Limited (MESO) are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios related to Mesoblast Limited (MESO).

What the Template Contains

  • Historical Data: Includes Mesoblast Limited’s (MESO) past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Mesoblast Limited’s (MESO) intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Mesoblast Limited’s (MESO) financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.